Alcidion
An Australian-listed supplier of flow, observations and tasking.
A note from public sources, read on 4 November 2026. Nothing here was verified by using the product. Vendor claims are claims. This is not a product review, and "not found" means only that the sources read did not say.
What it is
Alcidion Group is listed in Australia. Its main product is Miya Precision, which it describes as a FHIR-events platform, alongside Miya Observations and Assessments, the former Patientrack. Its markets are Australia, New Zealand and the UK.
Care settings
Acute inpatient care and emergency flow are its evidenced strengths. Community nursing records and primary care were not established.
Comparison
| Area | Alcidion | This project today |
|---|---|---|
| Scope | Modules for flow, tasking, noting, observations and results tracking | Scaffold: identity, consent, allergies, observations, referrals, audit |
| Interoperability | FHIR-events platform (vendor) | FHIR R4 and R5 reads for three resources; HL7 v2 ADT inbound |
| Mobile and patient access | Not found in the sources read | Mobile layout and patient portal not built |
Implications for this project
Separately purchased modules are one possible route to adoption. The closed-loop referral design could also apply to results, and an evaluation should be planned early.